UNSPSC 85471931: Bypass spinal canal to pleural cavity with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to bypass spinal canal to pleural cavity with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 001U374

UNSPSC 85471931 Bypass spinal canal to pleural cavity with autologous tissue substitute, percutaneous approach is a Commodity code tagged to state and local opportunities that bear no meaningful relationship to the code's nominal clinical scope. Recent state and local solicitations under this code encompass independent medical evaluation services for disability pension determinations, occupational health surveillance programs, surgical benefit carve-out networks, pharmacy benefit management, temporary health professional staffing, and specialty emergency care for detained youth—none of which involve the specific neurosurgical procedure the code nominally describes. The issuing bodies span municipal retirement boards, state transportation departments, county health systems, and county procurement offices. This code shows little relevant recent activity aligned with its stated clinical definition.

The recent opportunities cluster in Arizona, California, Florida, and Washington, with the most substantial procurement activity from the City of Phoenix Retirement Office (independent medical evaluation services, RFP RTMRFP26001, due October 16, 2026, $750,000 over five years), the Washington State Department of Transportation for Washington State Ferries (occupational medical surveillance, RFP RFP20260825, due October 9, 2026), the City of Long Beach (surgical benefit carve-out for Centers of Excellence, RFP HR26753, due October 7, 2026), and Collier County (pharmacy benefit management, RFP 25-8414, due April 9, 2026, approximately $8.7 million annually). The code's assignment to these opportunities appears procedurally incorrect rather than reflective of genuine clinical procurement in this specific surgical category.